Find similar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PLGB 04668/0360.
Fiasp 100 units/mL solution for injection in pre-filled pen (FlexTouch)
Fiasp® FlexTouch®
100 units/mL solution for injection in pre-filled pen
insulin aspart
1 What Fiasp® is and what it is used for
2 What you need to know before you use Fiasp®
3 How to use Fiasp®
4 Possible side effects
5 How to store Fiasp®
6 Contents of the pack and other information
Fiasp® is a mealtime insulin with a fast-acting blood sugar lowering effect. Fiasp® is a solution for injection containing insulin aspart and is used to treat diabetes mellitus in adults, adolescents and children aged 1 year and above. Diabetes is a disease where your body does not produce enough insulin to control the level of blood sugar. Treatment with Fiasp® helps to prevent complications from your diabetes.
Fiasp® should be injected up to 2 minutes before the start of the meal, with an option to inject up to 20 minutes after starting the meal.
This medicine has its maximum effect between 1 and 3 hours after the injection and the effect lasts for 3 to 5 hours.
This medicine should normally be used in combination with intermediate-acting or long-acting insulin preparations.
Talk to your doctor, pharmacist or nurse before using Fiasp®. Be especially aware of the following:
If you have poor eyesight, please see section 3 ‘How to use Fiasp®’.
Some conditions and activities can affect how much insulin you need. Talk to your doctor:
When using Fiasp® it is strongly recommended that the name and batch number of each package is recorded in order to maintain a record of the batches used.
Skin changes at the injection site
The injection site should be rotated to help prevent changes to the fatty tissue under the skin, such as skin thickening, skin shrinking or lumps under the skin. The insulin may not work very well if you inject into a lumpy, shrunken or thickened area (see section 3 ‘How to use Fiasp®’). Tell your doctor if you notice any skin changes at the injection site. Tell your doctor if you are currently injecting into these affected areas before you start injecting in a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.
This medicine is not recommended for use in children below the age of 1 year.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Some medicines affect your blood sugar level - this may mean your insulin dose has to change.
Listed below are the most common medicines which may affect your insulin treatment.
Your blood sugar level may fall (hypoglycaemia) if you take:
Your blood sugar level may rise (hyperglycaemia) if you take:
Octreotide and lanreotide - used to treat a rare condition involving too much growth hormone (acromegaly). They may increase or decrease your blood sugar level.
If any of the above applies to you (or you are not sure), talk to your doctor or pharmacist.
If you drink alcohol, your need for insulin may change as your blood sugar level may either rise or fall. You should therefore monitor your blood sugar level more often than usual.
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. This medicine can be used during pregnancy; however your insulin dose may need to be changed during pregnancy and after delivery. The amount of insulin you need usually falls during the first 3 months of pregnancy and increases for the remaining 6 months. Careful control of your diabetes is needed in pregnancy. Avoiding low blood sugar (hypoglycaemia) is particularly important for the health of your baby. After you have had your baby your insulin requirements will likely return to how much you needed before your pregnancy.
There are no restrictions on treatment with Fiasp® during breast-feeding.
Having low blood sugar can affect your ability to drive or use any tools or machines. If your blood sugar is low, your ability to concentrate or react might be affected. This could be dangerous to yourself or others. Ask your doctor whether you can drive if:
This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free’.
Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this pen without help. Get help from a person with good eyesight who is trained to use the FlexTouch® pre-filled pen.
The pre-filled pen can provide a dose of 1–80 units in one injection in steps of 1 unit.
Fiasp® is a mealtime insulin.
Adults: Fiasp® should be injected right before (0-2 minutes) the start of the meal, with an option to inject up to 20 minutes after starting the meal.
Children: Fiasp® should be injected right before (0-2 minutes) the start of the meal, with the possibility to inject up to 20 minutes after starting the meal in situations, when there is uncertainty about how the child will eat. Ask your doctor for advice on these situations.
This medicine has its maximum effect between 1 and 3 hours after the injection and the effect lasts for 3 to 5 hours.
Dose for type 1 and type 2 diabetes
Your doctor will decide together with you:
If you want to change your usual diet, check with your doctor, pharmacist or nurse first as a change in diet may alter your need for insulin.
When using other medicines, ask your doctor if your treatment needs to be adjusted.
Dose adjustment for type 2 diabetes
The daily dose should be based on your blood sugar level at mealtimes and bedtime from the previous day.
Dose adjustment for mealtime or bedtime blood sugar:
Reduce dose by one unit if less than 4mmol/L or less than 71 mg/dL
No dose adjustment for 4-6 mmol/L or 71-108 mg/dL
Increase dose by 1 unit if more than 6mmol/L or more than 108mg/dL
Use in elderly patients (65 years or older)
This medicine can be used in elderly patients. Talk to your doctor about changes in your dose.
If you have kidney or liver problems
If you have kidney or liver problems you may need to check your blood sugar level more often. Talk to your doctor about changes in your dose.
This medicine is only suitable for injection under the skin (subcutaneous injection).
Before you use Fiasp® for the first time, your doctor or nurse will show you how to use the pre-filled pen. Speak to your doctor if you need to inject your insulin by another method.
Detailed instructions on how to use your FlexTouch® pen are provided on the other side of this leaflet.
If you use too much insulin your blood sugar may get too low (hypoglycaemia), see advice in section 4 under ‘Low blood sugar’.
If you forget to use your insulin your blood sugar may get too high (hyperglycaemia). See section 4 under ‘High blood sugar’.
Do not stop using your insulin without talking to your doctor. If you stop using your insulin this could lead to a very high blood sugar level (severe hyperglycaemia) and ketoacidosis (a condition with too much acid in the blood which is potentially life-threatening). See symptoms and advice in section 4 under ‘High blood sugar’.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Low blood sugar (hypoglycaemia) is very common with insulin treatment (may affect more than 1 in 10 people). It can be very serious. If your blood sugar level falls too much you may become unconscious. Serious hypoglycaemia may cause brain damage and may be life-threatening. If you have symptoms of low blood sugar, take actions immediately to increase your blood sugar level. See advice in ‘Low blood sugar’ below.
If you have a serious allergic reaction (including an anaphylactic shock) to insulin or any of the ingredients in Fiasp® (how often this occurs is not known), stop using this medicine and contact emergency medical service straight away.
Signs of a serious allergic reaction may include:
Allergic reactions such as generalised skin rash and facial swelling may occur. These are uncommon and may affect up to 1 in 100 people. See a doctor if the symptoms worsen or you see no improvement in a few weeks.
Skin changes at the injection site: If you inject insulin at the same place, the fatty tissue may shrink (lipoatrophy) or thicken (lipohypertrophy) (these are uncommon and may affect up to 1 in 100 people). Lumps under the skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis; how often this occurs is not known). The insulin may not work very well if you inject into a lumpy, shrunken or thickened area. Change the injection site with each injection to help prevent these skin changes.
Common (may affect up to 1 in 10 people)
Reaction at administration site: Local reactions at the place you inject yourself may occur. The signs may include: rash, redness, inflammation, bruising, irritation, pain and itching. The reactions usually disappear after a few days.
Skin reactions: Signs of allergy on the skin such as eczema, rash, itching, hives and dermatitis may occur.
Low blood sugar may happen if you:
Drink alcohol; use too much insulin; exercise more than usual; eat too little or miss a meal.
Headache; slurred speech; fast heartbeat; cold sweat; cool pale skin; feeling sick; feeling very hungry; tremor or feeling nervous or worried; feeling unusually tired; weak and sleepy; feeling confused; difficulty in concentrating; short-lasting changes in your sight.
Tell everyone you spend time with that you have diabetes. Tell them what could happen if your blood sugar gets too low, including the risk of passing out.
Let them know that if you pass out, they must:
You may recover more quickly from passing out with an injection of glucagon. This can only be given by someone who knows how to use it.
If severe low blood sugar is not treated over time, it can cause brain damage. This can be short or long-lasting. It may even cause death.
This is because the dosing or timing of your insulin injections, food or exercise may need to be changed.
High blood sugar may happen if you:
Eat more or exercise less than usual; drink alcohol; get an infection or a fever; have not used enough insulin; keep using less insulin than you need; forget to use your insulin or stop using insulin.
Flushed skin; dry skin; feeling sleepy or tired; dry mouth; fruity (acetone) breath; urinating more often; feeling thirsty; losing your appetite; feeling or being sick (nausea or vomiting).
These may be signs of a very serious condition called ketoacidosis. This is a build-up of acid in the blood because the body is breaking down fat instead of sugar. If not treated, this could lead to diabetic coma and eventually death.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via
Great Britain:
or search for MHRA Yellow Card in the Google Play or Apple App Store
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton, after ‘EXP’. The expiry date refers to the last day of that month.
Before first use
Store in a refrigerator (2°C–8°C). Do not freeze. Keep away from the freezing element. Keep the cap on the pen in order to protect from light.
After first opening or if carried as a spare
You can carry your pre-filled pen (FlexTouch®) with you and keep it at room temperature (not above 30°C) or in a refrigerator (2°C–8°C) for up to 4 weeks. Always keep the cap on the pen when you are not using it in order to protect from light.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Fiasp® is presented as a clear, colourless and aqueous solution for injection in pre-filled pen.
Pack sizes of 1, 5 or a multipack with 2 x 5 pre-filled pens of 3 mL. Not all pack sizes may be marketed.
This leaflet was last revised in 08/2022
Fiasp®and FlexTouch®are trademarks owned by Novo Nordisk A/S, Denmark
© 2022
Novo Nordisk A/S
Please read these instructions carefully before using your FlexTouch® pre-filled pen. If you do not follow the instructions carefully, you may get too little or too much insulin, which can lead to high or low blood sugar level.
Do not use the pen without proper training from your doctor or nurse.
Start by checking your pen to make sure that it contains Fiasp® 100 units/mL, then look at the illustrations below to get to know the different parts of your pen and needle.
If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this pen without help. Get help from a person with good eyesight who is trained to use the FlexTouch® pre-filled pen.
Your pen is a pre-filled dial-a-dose insulin pen containing 300 units of insulin. You can select a maximum of 80 units per dose, in steps of 1 unit. Your pen is designed to be used with single-use, disposable injection needles of a length between 4 mm and 8 mm and a gauge between 30G and 32G. Needles are not included in the pack.
Pay special attention to these notes as they are important for correct use of the pen.
Fiasp® pre-filled pen and needle (example) (flextouch®)
Components of pen:
Make sure to attach the needle correctly.
The needle is covered by two caps. You must remove both caps. If you forget to remove both caps, you will not inject any insulin.
A drop of insulin may appear at the needle tip. This is normal, but you must still check the insulin flow.
Do not attach a new needle to your pen until you are ready for your injection.
Always use a new needle for each injection.
This reduces the risk of contamination, infection, leakage of insulin, blocked needles and inaccurate dosing.
Never use a bent or damaged needle.
This helps you to ensure that you get your full insulin dose.
Tap the top of the pen gently a few times to let any air bubbles rise to the top.
The 0 must line up with the dose pointer.
A drop of insulin should appear at the needle tip.
Always make sure that a drop appears at the needle tip before you inject. This makes sure that the insulin is flowing properly.
If no drop appears, no insulin will be injected, even though the dose counter may move. This may indicate a blocked or damaged needle.
Always check the flow before you inject. If you do not check the flow, you may get too little insulin or no insulin at all. This may lead to high blood sugar level.
The dose selector changes the number of units. Only the dose counter and dose pointer will show how many units you select per dose.
You can select up to 80 units per dose. When your pen contains less than 80 units, the dose counter stops at the number of units left.
Always use the dose counter and the dose pointer to see how many units you have selected before injecting the insulin.
Do not count the pen clicks to set the dose. If you select and inject the wrong dose, your blood sugar level may get too high or too low.
Do not use the insulin scale, it only shows approximately how much insulin is left in your pen.
The dose selector clicks differently when turned forwards, backwards or past the number of units left.
Do not touch the dose counter with your fingers. This could interrupt the injection.
If blood appears at the injection site, press lightly on the skin for a few minutes to stop the bleeding. Do not rub the area.
You may see a drop of insulin at the needle tip after injecting. This is normal and does not affect your dose.
Always watch the dose counter to know how many units you inject. Hold the dose button down until the dose counter shows 0. If the dose counter does not return to 0, the full dose has not been delivered, which may lead to high blood sugar level.
Remove the needle as described in section 5 and repeat all steps starting with section 1: Prepare your pen with a new needle. Make sure you select the full dose you need.
This can interrupt the injection.
Always dispose of the needle after each injection
This reduces the risk of contamination, infection, leakage of insulin, blocked needles and inaccurate dosing. If the needle is blocked, you will not inject any insulin.
When the pen is empty, throw it away without a needle on as instructed by your doctor, nurse, pharmacist or local authorities.
Never try to put the inner needle cap back on the needle. You may prick or injure yourself with the needle.
Always remove the needle from your pen after each injection and store your pen without the needle attached. This reduces the risk of contamination, infection, leakage of insulin, blocked needles and inaccurate dosing.
Be very careful to calculate correctly if splitting your dose.
If in doubt, take the full dose with a new pen. If you split the dose wrong, you will inject too little or too much insulin, which can lead to high or low blood sugar levels.
Further important information